Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance-Reference-Cited by-同舟云学术

Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance

Published:2019-05-22 Issue:4 Volume:146 Page:999-1009
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Engel Christoph¹^ORCID,Fischer Christine²,Zachariae Silke¹,Bucksch Karolin¹,Rhiem Kerstin³,Giesecke Jutta³,Herold Natalie³,Wappenschmidt Barbara³,Hübbel Verena³,Maringa Monika³,Reichstein‐Gnielinski Simone³,Hahnen Eric³^ORCID,Bartram Claus R.²,Dikow Nicola²,Schott Sarah⁴,Speiser Dorothee⁵,Horn Denise⁶,Fallenberg Eva M.⁷,Kiechle Marion⁸,Quante Anne S.⁸,Vesper Anne‐Sophie⁹,Fehm Tanja⁹,Mundhenke Christoph¹⁰,Arnold Norbert¹¹,Leinert Elena¹²,Just Walter¹³,Siebers‐Renelt Ulrike¹⁴,Weigel Stefanie¹⁵,Gehrig Andrea¹⁶,Wöckel Achim¹⁷,Schlegelberger Brigitte¹⁸,Pertschy Stefanie¹⁹,Kast Karin²⁰²¹²²,Wimberger Pauline²⁰²¹²²,Briest Susanne²³,Loeffler Markus¹,Bick Ulrich⁷,Schmutzler Rita K.³,

Affiliation:

1. Institute for Medical Informatics, Statistics and EpidemiologyUniversity of Leipzig Leipzig Germany

2. Institute of Human GeneticsRuprecht‐Karls University Heidelberg Germany

3. Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical FacultyUniversity Hospital Cologne Cologne Germany

4. Department of GynaecologyRuprecht‐Karls University Heidelberg Germany

5. Department of Gynecology with Breast Center, Charité – Universitätsmedizin Berlin, Freie Universität BerlinHumboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

6. Institute of Medical Genetics and Human Genetics, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität BerlinHumboldt‐Universität zu Berlin, and Berlin Institute of Health Berlin Germany

7. Department of RadiologyUniversity Hospital, LMU Munich Munich Germany

8. Department of Gynecology and ObstetricsUniversity Hospital Rechts der Isar, Technical University Munich Munich Germany

9. Department of Obstetrics and GynecologyUniversity Hospital and Medical Faculty of the Heinrich‐Heine University Duesseldorf Duesseldorf Germany

10. Department of Gynecology and ObstetricsUniversity Hospital of Schleswig‐Holstein, Christian‐Albrechts‐University Kiel Kiel Germany

11. Department of Gynecology and Obstetrics, Institute of Clinical Molecular BiologyUniversity Hospital of Schleswig‐Holstein, Christian‐Albrechts‐University Kiel Kiel Germany

12. Department of Gynecology and ObstetricsUlm University Hospital Ulm Germany

13. Institute of Human GeneticsUniversity of Ulm Ulm Germany

14. Institut für HumangenetikUniversitätsklinikum Münster Münster Germany

15. Institute of Clinical Radiology, Medical FacultyUniversity of Muenster, University Hospital Muenster Muenster Germany

16. Institute of Human GeneticsWürzburg University Würzburg Germany

17. Department of Obstetrics and GynecologyWürzburg University Hospital Würzburg Germany

18. Department of Human GeneticsHannover Medical School Hannover Germany

19. Department of Diagnostic and Interventional RadiologyHannover Medical School Hannover Germany

20. Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav CarusTechnische Universität Dresden Dresden Germany

21. National Center for Tumor Diseases (NCT)Partner Site Dresden Dresden Germany

22. German Cancer Consortium (DKTK)Dresden and German Cancer Research Center (DKFZ) Heidelberg Germany

23. Department of Obstetrics and GynecologyUniversity Hospital Leipzig Leipzig Germany

Funder

German Cancer Aid

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32396

Reference45 articles.

1. Meta-Analysis ofBRCA1andBRCA2Penetrance

2. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

3. Prevalence ofBRCA1/2germline mutations in 21 401 families with breast and ovarian cancer

4. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence;Ford D;Am J Hum Genet,1995

5. Breast and ovarian cancer incidence in BRCA1‐mutation carriers. Breast cancer linkage consortium;Easton DF;Am J Hum Genet,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-01-04

2. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making;Annals of Surgical Oncology;2023-10-09

3. Combining rare and common genetic variants improves population risk stratification for breast cancer;2023-05-19

4. Psychological distress and decision‐making factors for prophylactic bilateral mastectomy in cancer‐unaffected BRCA1/2 pathogenic variant carriers;Psycho-Oncology;2023-03-07

5. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy;European Journal of Cancer;2023-03